Michael E Miller1, Jay Magaziner2, Anthony P Marsh3, Roger A Fielding4, Thomas M Gill5, Abby C King6, Stephen Kritchevsky7, Todd Manini8, Mary M McDermott9, Rebecca Neiberg1, Denise Orwig2, Adam J Santanasto10, Marco Pahor8, Jack Guralnik2, W Jack Rejeski3. 1. Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 2. Department of Epidemiology and Public Health, School of Medicine, University of Maryland, Baltimore, Maryland. 3. Department of Health and Exercise Science, Wake Forest University, Winston-Salem, North Carolina. 4. Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts. 5. Department of Internal Medicine, Division of Geriatric Medicine, School of Medicine, Yale University, New Haven, Connecticut. 6. School of Medicine, Stanford University, Stanford, California. 7. Section on Gerontology and Geriatric Medicine, Department of Internal Medicine, Sticht Center for Healthy Aging and Alzheimer's Prevention, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 8. Department of Aging and Geriatric Research, College of Medicine, University of Florida, Gainesville, Florida. 9. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 10. Center for Aging and Population Health, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVES: To investigate the heterogeneity of clinically meaningful levels of gait speed relative to self-reported mobility disability (SR-MD). DESIGN: Five longitudinal studies with older adults in different health states (onset of acute event, presence of chronic condition, sedentary, community living) were used to explore the relationship between gait speed and SR-MD. SETTING: Lifestyle Interventions and Independence for Elders Pilot (LIFE-P), LIFE, Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN), Baltimore Hip Fracture Study (BHS2), Invecchiare in Chianti (InCHIANTI). PARTICIPANTS: Individuals aged 65 and older (N=3,540): sedentary, community dwelling (LIFE-P/LIFE), with hip fracture (BHS2), random population-based sample (InCHIANTI), high cardiovascular risk (TRAIN). MEASUREMENTS: Usual-pace gait speed across 3 to 4 m and SR-MD, defined as inability to walk approximately 1 block or climb 1 flight of stairs. RESULTS: The mean gait speed of participants without SR-MD was greater than 1.0 m/s in InCHIANTI and TRAIN, 0.79 m/s in LIFE-P/LIFE, and 0.46 m/sec in BHS2. Of individuals with SR-MD, mean gait speed was 0.08 m/s slower in LIFE-P/LIFE, 0.19 m/s slower in TRAIN, 0.22 m/s slower in BHS2, and 0.36 m/s slower in InCHIANTI. The optimal gait speed cutpoint for minimizing SR-MD misclassification rates ranged from 0.3 m/s in BHS2 to 1.0 m/s in TRAIN. In longitudinal analyses, development of SR-MD was dependent on initial gait speed and change in gait speed (p<.001). CONCLUSION: The relationship between absolute levels of gait speed and SR-MD may be context specific, and there may be variations between populations. Across diverse clinical populations, clinical interpretations of how change in usual pace gait speed relates to development of SR-MD depend on where on the gait speed continuum change occurs.
OBJECTIVES: To investigate the heterogeneity of clinically meaningful levels of gait speed relative to self-reported mobility disability (SR-MD). DESIGN: Five longitudinal studies with older adults in different health states (onset of acute event, presence of chronic condition, sedentary, community living) were used to explore the relationship between gait speed and SR-MD. SETTING: Lifestyle Interventions and Independence for Elders Pilot (LIFE-P), LIFE, Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN), Baltimore Hip Fracture Study (BHS2), Invecchiare in Chianti (InCHIANTI). PARTICIPANTS: Individuals aged 65 and older (N=3,540): sedentary, community dwelling (LIFE-P/LIFE), with hip fracture (BHS2), random population-based sample (InCHIANTI), high cardiovascular risk (TRAIN). MEASUREMENTS: Usual-pace gait speed across 3 to 4 m and SR-MD, defined as inability to walk approximately 1 block or climb 1 flight of stairs. RESULTS: The mean gait speed of participants without SR-MD was greater than 1.0 m/s in InCHIANTI and TRAIN, 0.79 m/s in LIFE-P/LIFE, and 0.46 m/sec in BHS2. Of individuals with SR-MD, mean gait speed was 0.08 m/s slower in LIFE-P/LIFE, 0.19 m/s slower in TRAIN, 0.22 m/s slower in BHS2, and 0.36 m/s slower in InCHIANTI. The optimal gait speed cutpoint for minimizing SR-MD misclassification rates ranged from 0.3 m/s in BHS2 to 1.0 m/s in TRAIN. In longitudinal analyses, development of SR-MD was dependent on initial gait speed and change in gait speed (p<.001). CONCLUSION: The relationship between absolute levels of gait speed and SR-MD may be context specific, and there may be variations between populations. Across diverse clinical populations, clinical interpretations of how change in usual pace gait speed relates to development of SR-MD depend on where on the gait speed continuum change occurs.
Authors: Mirjam J Knol; Ingeborg van der Tweel; Diederick E Grobbee; Mattijs E Numans; Mirjam I Geerlings Journal: Int J Epidemiol Date: 2007-08-27 Impact factor: 7.196
Authors: Dawn E Alley; Gregory E Hicks; Michelle Shardell; William Hawkes; Ram Miller; Rebecca L Craik; Kathleen K Mangione; Denise Orwig; Marc Hochberg; Barbara Resnick; Jay Magaziner Journal: J Am Geriatr Soc Date: 2011-08-24 Impact factor: 5.562
Authors: J Magaziner; W Hawkes; J R Hebel; S I Zimmerman; K M Fox; M Dolan; G Felsenthal; J Kenzora Journal: J Gerontol A Biol Sci Med Sci Date: 2000-09 Impact factor: 6.053
Authors: W Jack Rejeski; Roger A Fielding; Steven N Blair; Jack M Guralnik; Thomas M Gill; Evan C Hadley; Abby C King; Stephen B Kritchevsky; Michael E Miller; Anne B Newman; Marco Pahor Journal: Contemp Clin Trials Date: 2005-04 Impact factor: 2.226
Authors: J M Guralnik; A Z LaCroix; R D Abbott; L F Berkman; S Satterfield; D A Evans; R B Wallace Journal: Am J Epidemiol Date: 1993-04-15 Impact factor: 4.897
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Arlene Schmid; Pamela W Duncan; Stephanie Studenski; Sue Min Lai; Lorie Richards; Subashan Perera; Samuel S Wu Journal: Stroke Date: 2007-05-17 Impact factor: 7.914
Authors: Denise L Orwig; Danielle S Abraham; Marc C Hochberg; Ann Gruber-Baldini; Jack M Guralnik; Anne R Cappola; Justine Golden; Gregory E Hicks; Ram R Miller; Barbara Resnick; Michelle Shardell; Robert S Sterling; Rashmita Bajracharya; Jay Magaziner Journal: J Gerontol A Biol Sci Med Sci Date: 2022-07-05 Impact factor: 6.591
Authors: KaKi Tse; Rebecca H Neiberg; Daniel P Beavers; Stephen B Kritchevsky; Barbara J Nicklas; Dalane W Kitzman; W Jack Rejeski; Stephen P Messier; Kristen M Beavers Journal: J Gerontol A Biol Sci Med Sci Date: 2022-10-06 Impact factor: 6.591
Authors: Rossella Rizzo; Silvin P Knight; James R C Davis; Louise Newman; Eoin Duggan; Rose Anne Kenny; Roman Romero-Ortuno Journal: Geriatrics (Basel) Date: 2022-04-22
Authors: Chen Bai; Amal A Wanigatunga; Santiago Saldana; Ramon Casanova; Todd M Manini; Mamoun T Mardini Journal: Sensors (Basel) Date: 2022-04-15 Impact factor: 3.847
Authors: Peggy M Cawthon; Sheena M Patel; Stephen B Kritchevsky; Anne B Newman; Adam Santanasto; Douglas P Kiel; Thomas G Travison; Nancy Lane; Steven R Cummings; Eric S Orwoll; Kate A Duchowny; Timothy Kwok; Vasant Hirani; John Schousboe; Magnus K Karlsson; Dan Mellström; Claes Ohlsson; Östen Ljunggren; Qian-Li Xue; Michelle Shardell; Joanne M Jordan; Karol M Pencina; Roger A Fielding; Jay Magaziner; Rosaly Correa-de-Araujo; Shalender Bhasin; Todd M Manini Journal: J Gerontol A Biol Sci Med Sci Date: 2021-09-13 Impact factor: 6.591
Authors: Maria Giné-Garriga; Oriol Sansano-Nadal; Mark A Tully; Paolo Caserotti; Laura Coll-Planas; Dietrich Rothenbacher; Dhayana Dallmeier; Michael Denkinger; Jason J Wilson; Carme Martin-Borràs; Mathias Skjødt; Kelly Ferri; Ana Claudia Farche; Emma McIntosh; Nicole E Blackburn; Antoni Salvà; Marta Roqué-I-Figuls Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053